Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.

Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Lencina C, Lévêque M, Braniste V, Ménard S, Théodorou V, Houdeau E.

PLoS One. 2012;7(11):e49547. doi: 10.1371/journal.pone.0049547. Epub 2012 Nov 14.

2.

A new soy germ fermented ingredient displays estrogenic and protease inhibitor activities able to prevent irritable bowel syndrome-like symptoms in stressed female rats.

Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Houdeau E, Théodorou V.

Clin Nutr. 2013 Feb;32(1):51-8. doi: 10.1016/j.clnu.2012.05.021. Epub 2012 Jun 22.

PMID:
22727545
3.

Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.

Algieri F, Zorrilla P, Rodriguez-Nogales A, Garrido-Mesa N, Bañuelos O, González-Tejero MR, Casares-Porcel M, Molero-Mesa J, Zarzuelo A, Utrilla MP, Rodriguez-Cabezas ME, Galvez J.

J Ethnopharmacol. 2013 Apr 19;146(3):750-9. doi: 10.1016/j.jep.2013.01.041. Epub 2013 Feb 7.

PMID:
23395625
4.

Intestinal protease-activated receptor-2 and fecal serine protease activity are increased in canine inflammatory bowel disease and may contribute to intestinal cytokine expression.

Maeda S, Ohno K, Uchida K, Igarashi H, Goto-Koshino Y, Fujino Y, Tsujimoto H.

J Vet Med Sci. 2014 Aug;76(8):1119-27. Epub 2014 May 15.

6.

Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats.

Róka R, Ait-Belgnaoui A, Salvador-Cartier C, Garcia-Villar R, Fioramonti J, Eutamène H, Bueno L.

Gut. 2007 Aug;56(8):1072-8. Epub 2007 Feb 19.

7.

Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease.

Elli L, Ciulla MM, Busca G, Roncoroni L, Maioli C, Ferrero S, Bardella MT, Bonura A, Paliotti R, Terrani C, Braidotti P.

Lab Invest. 2011 Mar;91(3):452-61. doi: 10.1038/labinvest.2010.186. Epub 2010 Nov 1.

8.

Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.

Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L.

Gut. 2008 May;57(5):591-9. doi: 10.1136/gut.2007.140210. Epub 2008 Jan 14.

PMID:
18194983
9.

Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.

Choi KC, Cho SW, Kook SH, Chun SR, Bhattarai G, Poudel SB, Kim MK, Lee KY, Lee JC.

J Ethnopharmacol. 2016 Feb 17;179:55-65. doi: 10.1016/j.jep.2015.12.045. Epub 2015 Dec 22.

PMID:
26721217
10.

Antagonism of protease-activated receptor 2 protects against experimental colitis.

Lohman RJ, Cotterell AJ, Suen J, Liu L, Do AT, Vesey DA, Fairlie DP.

J Pharmacol Exp Ther. 2012 Feb;340(2):256-65. doi: 10.1124/jpet.111.187062. Epub 2011 Oct 25.

11.

Protease activated receptor 2: a new target for IBS treatment.

Bueno L.

Eur Rev Med Pharmacol Sci. 2008 Aug;12 Suppl 1:95-102. Review.

PMID:
18924448
12.

Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD.

Brenna Ø, Furnes MW, Drozdov I, van Beelen Granlund A, Flatberg A, Sandvik AK, Zwiggelaar RT, Mårvik R, Nordrum IS, Kidd M, Gustafsson BI.

PLoS One. 2013;8(1):e54543. doi: 10.1371/journal.pone.0054543. Epub 2013 Jan 31. Erratum in: PLoS One. 2014;9(6):e101382. PLoS One. 2013;8(5). doi:10.1371/annotation/af20399c-993e-436c-ad06-e0d8a657a7b4.

13.

Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.

Xu J, Zheng C, Huang Y, Liang Y.

Chin Med J (Engl). 2014;127(12):2368-75.

PMID:
24931258
14.

Protease-activated receptor-2 activation: a major actor in intestinal inflammation.

Hyun E, Andrade-Gordon P, Steinhoff M, Vergnolle N.

Gut. 2008 Sep;57(9):1222-9. doi: 10.1136/gut.2008.150722. Epub 2008 May 6.

PMID:
18460552
15.

Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis.

Zhu T, Liu TJ, Shi YY, Zhao Q.

Int J Mol Med. 2015 May;35(5):1213-8. doi: 10.3892/ijmm.2015.2150. Epub 2015 Mar 20.

16.

Protective effects of Pogostemon cablin Bentham water extract on inflammatory cytokine expression in TNBS-induced colitis in rats.

Park SY, Neupane GP, Lee SO, Lee JS, Kim MY, Kim SY, Park BC, Park YJ, Kim JA.

Arch Pharm Res. 2014 Feb;37(2):253-62. doi: 10.1007/s12272-013-0260-x. Epub 2013 Oct 30.

PMID:
24166708
17.

Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced inflammatory bowel disease.

Pawar P, Gilda S, Sharma S, Jagtap S, Paradkar A, Mahadik K, Ranjekar P, Harsulkar A.

BMC Complement Altern Med. 2011 Apr 28;11:34. doi: 10.1186/1472-6882-11-34.

18.

Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.

Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Diaz-Ropero MP, Olivares M, Xaus J, Zarzuelo A, Galvez J.

World J Gastroenterol. 2005 Sep 7;11(33):5185-92.

19.

Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.

Zwolinska-Wcislo M, Krzysiek-Maczka G, Ptak-Belowska A, Karczewska E, Pajdo R, Sliwowski Z, Urbanczyk K, Drozdowicz D, Konturek SJ, Pawlik WW, Brzozowski T.

J Physiol Pharmacol. 2011 Jun;62(3):357-68.

20.

Supplemental Content

Support Center